Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.02%34.03B | -2.39%32.4B | -4.78%7.93B | -2.44%8.29B | -0.79%8.29B | -1.51%7.89B | 8.43%33.19B | 9.66%8.32B | 11.78%8.5B | 8.42%8.36B |
| Cost of revenue | 4.18%24.31B | -2.81%23.34B | -3.11%5.79B | -4.30%5.83B | -2.76%6.03B | -0.96%5.69B | 11.14%24.01B | 9.13%5.97B | 16.93%6.09B | 13.96%6.21B |
| Gross profit | 7.18%9.72B | -1.28%9.07B | -8.98%2.14B | 2.24%2.46B | 4.87%2.26B | -2.91%2.21B | 1.95%9.18B | 11.01%2.35B | 0.63%2.41B | -4.90%2.15B |
| Operating expense | 7.89%4.27B | 6.40%3.96B | 0.00%1.01B | 18.92%1.06B | 3.29%974M | 4.46%913M | 8.37%3.72B | 10.60%1.01B | 7.51%888M | 11.07%943M |
| Staff costs | 7.03%1.95B | 1.11%1.82B | -3.11%624M | 21.85%435M | -0.50%398M | -9.00%364M | 2.27%1.8B | 2.22%644M | -4.55%357M | 4.44%400M |
| Selling and administrative expenses | 9.78%1.17B | 8.91%1.06B | ---- | ---- | ---- | ---- | 22.31%976M | ---- | ---- | ---- |
| -Selling and marketing expense | 2.22%46M | 7.14%45M | ---- | ---- | ---- | ---- | 90.91%42M | ---- | ---- | ---- |
| -General and administrative expense | 10.12%1.12B | 8.99%1.02B | ---- | ---- | ---- | ---- | 20.36%934M | ---- | ---- | ---- |
| Depreciation and amortization | 22.92%177M | 44.00%144M | ---- | ---- | ---- | ---- | 0.00%100M | ---- | ---- | ---- |
| -Depreciation | 22.92%177M | 44.00%144M | ---- | ---- | ---- | ---- | 0.00%100M | ---- | ---- | ---- |
| Rent and land expenses | --1M | --0 | ---- | ---- | ---- | ---- | 0.00%1M | ---- | ---- | ---- |
| Other operating expenses | 4.96%973M | 10.49%927M | -15.51%-819M | 16.95%621M | 6.08%576M | 15.82%549M | 8.96%839M | -15.47%-709M | 17.48%531M | 16.52%543M |
| Operating profit | 6.63%5.45B | -6.51%5.11B | -15.77%1.13B | -7.50%1.41B | 6.11%1.29B | -7.52%1.29B | -1.99%5.47B | 11.31%1.34B | -3.00%1.52B | -14.48%1.21B |
| Net non-operating interest income (expenses) | 0.00%4M | 300.00%4M | 300.00%2M | 1M | 1M | 0 | 66.67%-2M | 0.00%-1M | 0 | 0 |
| Non-operating interest income | -28.57%5M | 40.00%7M | --2M | 0.00%2M | 0.00%2M | 0.00%1M | 0.00%5M | --0 | 100.00%2M | 100.00%2M |
| Non-operating interest expense | -66.67%1M | -57.14%3M | --0 | -50.00%1M | -50.00%1M | -50.00%1M | -36.36%7M | -66.67%1M | 0.00%2M | -33.33%2M |
| Net investment income | -200.00%-71M | -31.07%71M | 108.33%6M | -273.33%-26M | -49.46%47M | -34.33%44M | 347.83%103M | -72M | 15M | 420.69%93M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -163.50%-87M | 552.38%137M | -169.70%-23M | 1,783.33%101M | 66.67%-1M | 2,100.00%60M | 107.07%21M | 512.50%33M | -50.00%-6M | 98.95%-3M |
| Less:Other special charges | 150.93%82M | -666.67%-161M | 96.97%-1M | -1,783.33%-101M | -66.67%1M | -2,100.00%-60M | -107.07%-21M | -512.50%-33M | 50.00%6M | --3M |
| Less:Write off | -79.17%5M | --24M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | -58.20%51M | 125.93%122M | 140.91%53M | 0.00%12M | 241.67%41M | 100.00%16M | 28.57%54M | 0.00%22M | 200.00%12M | 12M |
| Income before tax | -1.78%5.34B | -3.53%5.44B | -11.85%1.16B | -3.11%1.49B | 4.65%1.37B | -3.81%1.41B | 5.46%5.64B | 6.64%1.32B | -1.78%1.54B | 18.63%1.31B |
| Income tax | -1.49%1.59B | -10.48%1.61B | -44.50%227M | 6.05%473M | -9.64%375M | 1.13%539M | 6.88%1.8B | 6.79%409M | -0.67%446M | 9.21%415M |
| Net income | -1.93%3.75B | -0.23%3.83B | 2.97%935M | -6.86%1.02B | 11.26%998M | -6.63%873M | 4.81%3.83B | 6.57%908M | -2.32%1.09B | 23.72%897M |
| Net income continuous operations | -1.91%3.75B | -0.26%3.83B | 2.86%934M | -6.85%1.02B | 11.26%998M | -6.63%873M | 4.81%3.84B | 6.57%908M | -2.23%1.1B | 23.55%897M |
| Noncontrolling interests | -33.33%2M | -25.00%3M | 0.00%1M | 0.00%1M | 0.00%1M | 0 | 0.00%4M | 0.00%1M | 0.00%1M | 0.00%1M |
| Net income attributable to the company | -1.91%3.75B | -0.21%3.82B | 2.98%934M | -6.86%1.02B | 11.27%997M | -6.54%872M | 4.82%3.83B | 6.58%907M | -2.23%1.09B | 23.59%896M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -1.91%3.75B | -0.21%3.82B | 2.98%934M | -6.86%1.02B | 11.27%997M | -6.54%872M | 4.82%3.83B | 6.58%907M | -2.23%1.09B | 23.59%896M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 14.44%624.83M | -14.46%546M | -11.73%133.43M | -20.16%145.57M | 29.82%166.17M | 9.04%145.33M | 22.29%638.33M | 24.34%151.17M | 14.06%182.33M | 23.59%128M |
| Diluted earnings per share | 14.44%624.83M | -14.46%546M | -11.73%133.43M | -20.16%145.57M | 29.82%166.17M | 9.04%145.33M | 22.29%638.33M | 24.34%151.17M | 14.06%182.33M | 23.59%128M |
| Dividend per share | 0.00%326.66M | 50.00%326.66M | 50.00%326.66M | 0 | 0 | 0 | 33.33%217.77M | 33.33%217.77M | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |